MCP Waters-The Science of What's Possible
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on July 1, 2008.
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700505-MCP200v1
7/7/1241    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gillet, L. C. J.
Right arrow Articles by Gil-Parrado, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillet, L. C. J.
Right arrow Articles by Gil-Parrado, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on October 17, 2007
Revised on February 29, 2008
Accepted on March 24, 2008

In-cell selectivity profiling of serine protease inhibitors by activity-based proteomics

Ludovic C. J. Gillet, Kenji Namoto, Alexandra Ruchti, Sjouke Hoving, Danielle Boesch, Bruno Inverardi, Dieter Mueller, Michele Coulot, Patrick Schindler, Patrick Schweigler, Anna Bernardi, and Shirley Gil-Parrado

Expertise Platform Proteases, Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Basel, Basel CH-4002

Corresponding Author: shirley.gil_parrado{at}novartis.com

Activity-based proteomics is a methodology which is used to quantify the catalytically active sub-fraction of enzymes present in complex mixtures such as lysates or living cells. In order to apply this approach for in-cell selectivity profiling of inhibitors of serine proteases, we have designed a novel activity-based probe (ABP). This ABP consists of (i), a fluorophosphonate reactive group, directing the probe towards serine hydrolases or proteases and (ii), an alkyne functionality which can be specifically detected at a later stage with an azide-functionalized reporter group through a copper(I)-catalyzed coupling reaction ("click-chemistry"). This novel ABP was shown to label the active site of several serine proteases with greater efficiency than a previously reported fluorophosphonate probe. More importantly, our probe was cell-permeable and achieved labeling of enzymes within living cells with similar efficiency to that observed for the corresponding lysate fraction. Several endogenous serine hydrolases, whose activities were detected upon in-cell labeling, were identified by 2D gel and MS analyses. As a proof of principle, cell-permeable inhibitors of an endogenous serine protease (prolyl endopeptidase)were assessed for their potency and specificity in competing for the in-situ labeling of the selected enzyme. Altogether, these results open new perspectives for safety profiling studies in uncovering potential cellular "side-effects" of drugs (unanticipated off-target inhibition or activation) which may be overlooked by standard selectivity profiling methods.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.